Remove Digital Care Remove Integration Remove Regulations Remove Remote Care
article thumbnail

CNS Year in Review: Going Digital

Health Advances

Notably several companies have begun to integrate digital biomarkers as exploratory endpoints in their clinical trials. Thus, CNS-focused biopharmas should carefully consider digital biomarkers as they chart development paths. Biopharma companies have taken notice of these technologies and invested in them.